NCT04885933View on ClinicalTrials.gov

The Impact of Sarcopenia on COPD Exacerbation Admission Outcome and Further Exacerbation Risk

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

June 21, 2020

Conditions
SarcopeniaCOPD Exacerbation
Interventions
DIAGNOSTIC_TEST

sarcopenia measurement

BIA for fat free muscle mass hand grasp strength

Trial Locations (1)

220

Far Eastern Memorial Hospital, New Taipei City

All Listed Sponsors
lead

Far Eastern Memorial Hospital

OTHER

NCT04885933 - The Impact of Sarcopenia on COPD Exacerbation Admission Outcome and Further Exacerbation Risk | Biotech Hunter | Biotech Hunter